Overview of the actions of glucocorticoids on the immune response: A good model to characterize new pathways of immunosuppression for new treatment strategies

Annals of the New York Academy of Sciences

Volumn 1024, Issue , 2004, Pages 124-137

  Franchimont, D ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Adaptive immunity; Glucocorticoids; Immune response; Innate immunity; Tolerance

Indexed keywords

GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10;

ADJUVANT THERAPY; ADOPTIVE IMMUNOTHERAPY; AUTOIMMUNE DISEASE; CELL MATURATION; CELLULAR IMMUNITY; CONFERENCE PAPER; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG INDICATION; DRUG MECHANISM; DRUG POTENCY; EX VIVO STUDY; EXPERIMENTAL MODEL; GENETIC REGULATION; GRAFT REJECTION; HORMONE ACTION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; MOLECULAR DYNAMICS; NONHUMAN; PHARMACODYNAMICS; SIDE EFFECT; TH1 CELL; TH2 CELL;

EID: 3042833447     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1321.009     Document Type: Conference Paper

References (92)

1. COX, G. 1995. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J. Immunol. 154: 4719-4725.
2. LILES, W.C., D.C. DALE & S.J. KLEBANOFF. 1995. Glucocorticoids inhibit apoptosis of human neutrophils. Blood 86: 3181-3188.
3. MEAGHER, L.C., J.M. COUSIN, J.R. SECKL & C. HASLETT. 1996. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J. Immunol. 156: 4422-44428.
4. SCHLEIMER, R.P. & B.S. BOCHNER. 1994. The effects of glucocorticoids on human eosinophils. J. Allergy Clin. Immunol. 94: 1202-1213.
5. YOSHIMURA, C., M. MIYAMASU, H. NAGASE, et al. 2001. Glucocorticoids induce basophil apoptosis. J. Allergy Clin. Immunol. 108: 215-220.
6. RIDDICK, C.A., W.L. RING, J.R. BAKER, et al. 1997 Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells. Eur. J. Biochem. 246: 112-118.
7. STANKOVA, J., S. TURCOTTE, J. HARRIS, et al. 2002. Modulation of leukotriene B4 receptor-1 expression by dexamethasone: potential mechanism for enhanced neutrophil survival. J. Immunol. 168: 3570-3576.
8. CRONSTEIN, B.N., S.C. KIMMEL, R.I. LEVIN, et al. 1992. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA 89: 9991-9995.
9. NAKAGAWA, M., G.P. BONDY, D. WAISMAN, et al. 1999. The effect of glucocorticoids on the expression of L-selectin on polymorphonuclear leukocyte. Blood 93: 2730-2737.
10. FILEP, J.G., A. DELALANDRE, Y. PAYETTE & E. FOLDES-FILEP. 1997. Glucocorticoid receptor regulates expression of L-selectin and CD11/CD18 on human neutrophils. Circulation 96: 295-301.
11. JILMA, B. & P. STOHLAWETZ. 1998. Dexamethasone downregulates L-selectin in vitro and in vivo. Circulation 97: 2279-2281.
12. PERRETTI, M., J.D. CROXTALL, S.K. WHELLER, et al. 1996. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat. Med. 2: 1259-1262.
13. STRAUSBAUGH, H.J. & S.D. ROSEN. 2001. A potential role for annexin 1 as a physiologic mediator of glucocorticoid-induced L-selectin shedding from myeloid cells. J. Immunol. 166: 6294-6300.
14. STRAUSBAUGH, H.J., P.G. GREEN, E. LO, et al. 1999. Painful stimulation suppresses joint inflammation by inducing shedding of L-selectin from neutrophils. Nat. Med. 5: 1057-1061.
15. GRENIER, A., M. DEHOUX, A. BOUTTEN, et al. 1999. Oncostatin M production and regulation by human polymorphonuclear neutrophils. Blood 93: 1413-1421.
16. WERTHEIM, W.A., S.L. KUNKEL, T.J. STANDIFORD, et al. 1993. Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. J. Immunol. 151: 2166-2175.
17. STELLATO, C., L.A. BECK, G.A. GORGONE, et al. 1995. Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J. Immunol. 155: 410-418.
18. PYPE, J.L., L.J. DUPONT, P. MENTEN, et al. 1999. Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines. Am. J. Respir. Cell Mol. Biol. 21: 528-536.
19. JAHNSEN, F.L., R. HAYE, E. GRAN, et al. 1999. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia. J. Immunol. 163: 1545-1551.
20. NAGASE, H., M. MIYAMASU, M. YAMAGUCHI, et al. 2000. Glucocorticoids preferentially upregulate functional CXCR4 expression in eosinophils. J. Allergy Clin. Immunol. 106: 1132-1139.
21. LIU, Y., J.M. COUSIN, J. HUGHES, et al. 1999. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J. Immunol. 162: 3639-3646.
22. PIEMONTI, L., P. MONTI, P. ALLAVENA, et al. 1999. Glucocorticoids affect human dendritic cell differentiation and maturation. J. Immunol. 162: 6473-6481.
23. VAN DER GOES, A., K. HOEKSTRA, T.K. VAN DEN BERG & C.D. DIJKSTRA. 2000. Dexamethasone promotes phagocytosis and bacterial killing by human monocytes/macrophages in vitro. J. Leukoc. Biol. 67: 801-807.
24. HOGGER, P., J. DREIER, A. DROSTE, et al. 1998. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J. Immunol. 161: 1883-1890.
25. PIEMONTI, L., P. MONTI, P. ALLAVENA, et al. 1999. Glucocorticoids increase the endocytic activity of human dendritic cells. Int. Immunol. 11: 1519-1526.
26. PAN, L.Y., D.B. MENDEL, J. ZURLO & P.M. GUYRE. 1990. Regulation of the steady state level of Fc gamma RI mRNA by IFN-gamma and dexamethasone in human monocytes, neutrophils, and U-937 cells. J. Immunol. 145: 267-275.
27. BATUMAN, O.A., A. FERRERO, C. CUPP, et al. 1995. Differential regulation of transforming growth factor beta-1 gene expression by glucocorticoids in human T and glial cells. J. Immunol. 155: 4397-4405.
28. ELENKOV, I.J., D.A. PAPANICOLAOU, R.L. WILDER & G.P. CHROUSOS. 1996. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc. Assoc. Am. Physicians 108: 374-381.
29. FRANCHIMONT, D., H. MARTENS, M.T. HAGELSTEIN, et al. 1999. Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J. Clin. Endocrinol. Metab. 84: 2834-2839.
30. GALON, J., D. FRANCHIMONT, N. HIROI, et al. 2002. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 16: 61-71.
31. RAMIERZ, F., D.J. FOWELL, M. PUKLAVEC, et al. 1996. Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J. Immunol. 156: 2406-2412.
32. RE, F., M. MUZIO, M. DE ROSSI, et al. 1994. The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J. Exp. Med. 179: 739-743.
33. BERNHAGEN, J., T. CALANDRA, R.A. MITCHELL, et al. 1993. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365: 756-759.
34. CALANDRA, T., J. BERNHAGEN, C.N. METZ, et al. 1995. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377: 68-71.
35. CALANDRA, T., B. ECHTENACHER, D.L. ROY, et al. 2000. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 6: 164-170.
36. DONNELLY, S.C., C. HASLETT, P.T. REID, et al. 1997. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat. Med. 3: 320-323.
37. ROGER, T., J. DAVID, M.P. GLAUSER & T. CALANDRA. 2001. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414: 920-924.
38. SEBALDT, R.J., J.R. SHELLER, J.A. OATES, et al. 1990. Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proc. Natl. Acad. Sci. USA 87: 6974-6978.
39. YOSS, E.B., E.W. SPANNHAKE, J.T. FLYNN, et al. 1990. Arachidonic acid metabolism in normal human alveolar macrophages: stimulus specificity for mediator release and phospholipid metabolism, and pharmacologic modulation in vitro and in vivo. Am. J. Respir. Cell Mol. Biol. 2: 69-80.
40. NEWTON, R., J. SEYBOLD, L.M. KUITERT, et al. 1998. Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. J. Biol. Chem. 273: 32312-32321.
41. COWBURN, A.S., S.T. HOLGATE & A.P. SAMPSON. 1999. AP. IL-5 increases expression of 5-lipoxygenase-activating protein and translocates 5-lipoxygenase to the nucleus in human blood eosinophils. J. Immunol. 163: 456-465.
42. POULIOT, M., P.P. MCDONALD, P. BORGEAT & S.R. MCCOLL. 1994. Granulocyte/macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils. J. Exp. Med. 179: 1225-1232.
43. UZ, T., Y. DWIVEDI, A. QELI, et al. 2001. Glucocorticoid receptors are required for up-regulation of neuronal 5-lipoxygenase (5LOX) expression by dexamethasone. FASEB J. 15: 1792-1794.
44. AMEZAGA, M.A., F. BAZZONI, C. SORIO, et al. 1992. Evidence for the involvement of distinct signal transduction pathways in the regulation of constitutive and interferon gamma-dependent gene expression of NADPH oxidase components (gp91-phox, p47-phox, and p22-phox) and high-affinity receptor for IgG (Fc gamma R-I) in human polymorphonuclear leukocytes. Blood 79: 735-744.
45. SALVEMINI, D., P.T. MANNING, B.S. ZWEIFEL, et al. 1995. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J. Clin. Invest. 96: 301-308.
46. PALUCKA, K. & J. BANCHEREAU. 1999. J. Linking innate and adaptive immunity. Nat. Med. 5: 868-870.
47. MELLMAN, I. & R.M. STEINMAN. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106: 255-258.
48. ADEREM, A. & R.J. ULEVITCH. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406: 782-787.
49. KADOWAKI, N., S. HO, S. ANTONENKO, et al. 2001. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194: 863-869.
50. PULENDRAN, B., K. PALUCKA & J. BANCHEREAU. 2001. Sensing pathogens and tuning immune responses. Science 293: 253-256.
51. BANCHEREAU, J. & R.M. STEINMAN. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
52. LANZAVECCHIA, A. & F. SALLUSTO. 2001. Regulation of T cell immunity by dendritic cells. Cell 106: 263-266.
53. VANDERHEYDE, N., V. VERHASSELT, M. GOLDMAN & F. WILLEMS. 1999. Inhibition of human dendritic cell functions by methylprednisolone. Transplantation 67: 1342-1347.
54. MATYSZAK, M.K., S. CITTERIO, M. RESCIGNO & P. RICCIARDI-CASTAGNOLI. 2000. Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur. J. Immunol. 30: 1233-1242.
55. BLOTTA, M.H., R.H. DEKRUYFF & D.T. UMETSU. 1997. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce DL-4 synthesis in CD4+ lymphocytes. J. Immunol. 158: 5589-5595.
56. VIEIRA, P.L., P. KALINSKI, E.A. WIERENGA, et al. 1998. Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J. Immunol. 161: 5245-5251.
57. DEKRUYFF, R.H., Y. FANG & D.T. UMETSU. 1998. Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production. J. Immunol. 160: 2231-2237.
58. WU, C.Y., K. WANG, J.F. MCDYER & R.A. SEDER. 1998. Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol. 161: 2723-2730.
59. FRANCHIMONT, D., J. GALON, M. GADINA, et al. 2000. Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J. Immunol. 164: 1768-1774.
60. KAPLAN, M.H., Y.L. SUN, T. HOEY & M.J. GRUSBY. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382: 174-177.
61. BARRAT, F.J., D.J. CUA, A. BOONSTRA, et al. 2002. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195: 603-616.
62. AKDIS, C.A., T. BLESKEN, M. AKDIS, et al. 2001. Glucocorticoids inhibit human antigen-specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro. Eur. J. Immunol. 27: 2351-2357.
63. BARNES, P.J. 2001. Corticosteroids, IgE, and atopy. J. Clin. Invest. 107: 265-266.
64. KIMATA, H., I. LINDLEY & K. FURUSHO. 1995. Effect of hydrocortisone on spontaneous IgE and IgG4 production in atopic patients. J. Immunol. 154: 3557-3566.
65. CUPPS, T.R., L.C. EDGAR, C.A. THOMAS & A.S. FAUCI. 1984. Multiple mechanisms of B cell immunoregulation in man after administration of in vivo corticosteroids. J. Immunol. 132: 170-175.
66. CUPPS, T.R., T.L. GERRARD, R.J. FALKOFF, et al. 1985. Effects of in vitro corticosteroids on B cell activation, proliferation, and differentiation. J. Clin. Invest. 75: 754-761.
67. JABARA, H.H., D.J. AHERN, D. VERCELLI & R.S. GEHA. 1991. Hydrocortisone and IL-4 induce IgE isotype switching in human B cells. J. Immunol. 147: 1557-1560.
68. JABARA, H.H., R. LOH, N. RAMESH, et al. 1993. Sequential switching from mu to epsilon via gamma 4 in human B cells stimulated with IL-4 and hydrocortisone. J. Immunol. 151: 4528-4533.
69. WU, C.Y., M. SARFATI, C. HEUSSER, et al. 2001. Glucocorticoids increase the synthesis of immunoglobulin E by interleukin 4-stimulated human lymphocytes. J. Clin. Invest. 87: 870-877.
70. JABARA, H.H., S.R. BRODEUR & R.S. GEHA. 2001. Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching. J. Clin. Invest. 107: 371-378.
71. MIYAMASU, M., Y. MISAKI, S. IZUMI, et al. 1998. Glucocorticoids inhibit chemokine generation by human eosinophils. J. Allergy Clin. Immunol. 101: 75-83.
72. MURAKAMI, M., C.O. BINGHAM, 3RD, R. MATSUMOTO, et al. 1995. IgE-dependent activation of cytokine-primed mouse cultured mast cells induces a delayed phase of prostaglandin D2 generation via prostaglandin endoperoxide synthase-2. J. Immunol. 155: 4445-4453.
73. FINOTTO, S., Y.A. MEKORI & D.D. METCALFE. 1997. Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems. J. Clin. Invest. 99: 1721-1728.
74. EKLUND, K.K., D.E. HUMPHRIES, Z. XIA, et al. 1997. Glucocorticoids inhibit the cytokine-induced proliferation of mast cells, the high affinity IgE receptor-mediated expression of TNF-alpha, and the IL-10-induced expression of chymases. J. Immunol. 158: 4373-4380.
75. CISSEL, D.S. & M.A. BEAVEN. 2000. Disruption of Raf-1/heat shock protein 90 complex and Raf signaling by dexamethasone in mast cells. J. Biol. Chem. 275: 7066-7070.
76. SCHWIEBERT, L.M., L.A. BECK, C. STELLATO, et al. 1996. Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. J. Allergy Clin. Immunol. 97: 143-152.
77. WERSHIL, B.K., G.T. FURUTA, J.A. LAVIGNE, et al. 1995. Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades. Multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouse. J. Immunol. 154: 1391-1398.
78. YOSHIKAWA, H., Y. NAKAJIMA & K. TASAKA. 1999. Glucocorticoid suppresses autocrine survival of mast cells by inhibiting IL-4 production and ICAM-1 expression. J. Immunol. 162: 6162-6170.
79. ZACHARCHUK, C.M., M. MERCEP, P.K. CHAKRABORTI, et al. 1990. Programmed T lymphocyte death. Cell activation- and steroid-induced pathways are mutually antagonistic. J. Immunol. 145: 4037-4045.
80. VAN LAETHEM, F., E. BAUS, L.A. SMYTH, et al. 2001. Glucocorticoids attenuate T cell receptor signaling. J. Exp. Med. 193: 803-814.
81. PURTON, J.F., R.L. BOYD, T.J. COLE & D.I. GODFREY. 2000. Intrathymic T cell development and selection proceeds normally in the absence of glucocorticoid receptor signaling. Immunity 13: 179-186.
82. GONZALO, J.A., A. GONZALEZ-GARCIA, C. MARTINEZ & G. KROEMER. 1993. Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo. J. Exp. Med. 177: 1239-1246.
83. FRANCHIMONT, D., J. GALON, M.S. VACCHIO, et al. 2002. Positive effects of glucocorticoids on T cell function by up-regulation of IL-7 receptor alpha. J. Immunol. 168: 2212-2218.
84. PUEL, A., S.F. ZIEGLER, R.H. BUCKLEY & W.J. LEONARD. 1998. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat. Genet. 20: 394-397.
85. VON FREEDEN-JEFFRY, U., P. VIEIRA, L.A. LUCIAN, et al. 1995. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181: 1519-1526.
86. PESCHON, J.J., P.J. MORRISSEY, K.H. GRABSTEIN, et al. 1994. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180: 1955-1960.
87. SCHLUNS, K.S., W.C. KIEPER, J.C. JAMESON & L. LEFRANCOIS. 2000. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1: 426-432.
88. CHROUSOS, G.P. 1995. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332: 1351-1362.
89. JONULEIT, H., E. SCHMITT, G. SCHULER, et al. 2000. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192: 1213-1222.
90. READ, S. & F. POWRIE. 2001. CD4(+) regulatory T cells. Curr. Opin. Immunol. 13: 644-649.
91. DOZMOROV, I.M. & R.A. MILLER. 1998. Generation of antigen-specific Th2 cells from unprimed mice in vitro: effects of dexamethasone and anti-IL-10 antibody. J. Immunol. 160: 2700-2705.
92. BANCHEREAU, J., B. SCHULER-THURNER, A.K. PALUCKA & G. SCHULER. 2001. Dendritic cells as vectors for therapy. Cell 106: 271-274.